This article is more than 5 years old. Information may no longer be current.

Ask the Experts: What Are You Looking Forward to Most at TCT 2017?

Issue: September/October 2017

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

Members of the Cardiology Today’s Intervention Editorial Board reveal which presentations pique their interest.

Click here to see the to view the experts.

Disclosures: Angiolillo reports he has financial ties with Amgen, Aralez, AstraZeneca, Bayer, Biosensors, Bristol-Myers Squibb, CeloNova, Chiesi, CSL Behring, Daiichi Sankyo, Eisai, Eli Lilly, Gilead, Janssen, Matsutani, Merck, Novartis, Osprey Medical, PLx Pharma, Pfizer, Renal Guard Solutions, Sanofi, St. Jude Medical and The Medicines Company. Bavry reports receiving honoraria from the American College of Cardiology. Kern reports he is a speaker and consultant for Abbott/St. Jude Medical, Acist Medical, Opsens Inc. and Philips Volcano. Klein reports no relevant financial disclosures. Rao reports he receives research funding from Bellerophon and consults for Terumo Medical, The Medicines Company and Zoll.